CA2707300C - Rapid-read gated amperometry - Google Patents
Rapid-read gated amperometry Download PDFInfo
- Publication number
- CA2707300C CA2707300C CA2707300A CA2707300A CA2707300C CA 2707300 C CA2707300 C CA 2707300C CA 2707300 A CA2707300 A CA 2707300A CA 2707300 A CA2707300 A CA 2707300A CA 2707300 C CA2707300 C CA 2707300C
- Authority
- CA
- Canada
- Prior art keywords
- pulse
- seconds
- excitation pulse
- sample
- analyte
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/28—Electrolytic cell components
- G01N27/30—Electrodes, e.g. test electrodes; Half-cells
- G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/28—Electrolytic cell components
- G01N27/30—Electrodes, e.g. test electrodes; Half-cells
- G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
- G01N27/3271—Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood
- G01N27/3273—Devices therefor, e.g. test element readers, circuitry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/416—Systems
Abstract
A sensor system, device, and methods for determining the concentration of an analyte in a sample is described. Input signals including multiple duty cycles of sequential excitation pulses and relaxations are input to the sample. One or more signals output from the sample within 300 ms of the input of an excitation pulse may be correlated with the analyte concentration of the sample to improve the accuracy and/or precision of the analysis. Determining the analyte concentration of the sample from these rapidly measured output values may reduce analysis errors arising from the hematocrit effect, mediator background, and other error sources.
Description
RAPID-READ GATED AMPEROMETRY
BACKGROUND
1002] Biosensors provide an analysis of a biological fluid, such as whole blood, serum, plasma, urine, saliva, interstitial, or intracellular fluid.
Typically, biosensors have a measurement device that analyzes a sample residing in a sensor strip. The sample usually is in liquid form and in addition to being a biological fluid, may be the derivative of a biological fluid, such as an extract, a dilution, a filtrate, or a reconstituted precipitate. The analysis performed by the biosensor determines the presence and/or concentration of one or more analytes, such as alcohol, glucose, uric acid, lactate, cholesterol, bilirubin, free fatty acids, triglycerides, proteins, ketones, phenylalanine or enzymes, in the biological fluid.
The analysis may be useful in the diagnosis and treatment of physiological abnormalities. For example, a diabetic individual may use a biosensor to determine the glucose level in whole blood for adjustments to diet and/or medication.
1003] Biosensors may be designed to analyze one or more analytes and may use different sample volumes. Some biosensors may analyze a single drop of whole blood, such as from 0.25-15 microliters (pL) in volume. Biosensors may be implemented using bench-top, portable, and like measurement devices. Portable measurement devices may be hand-held and allow for the identification and/or quantification of one or more analytes in a sample. Examples of portable measurement devices include the Ascensia Breeze and Elite meters of Bayer HealthCare in Tarrytown, New York, while examples of bench-top measurement devices include the Electrochemical Workstation available from CH Instruments in Austin, Texas. Biosensors providing shorter analysis times, while supplying the desired accuracy and/or precision, provide a substantial benefit to the user.
[004] Biosensors may use optical and/or electrochemical methods to analyze the sample. In some optical systems, the analyte concentration is determined by measuring light that has interacted with or been absorbed by a light-identifiable species, such as the analyte or a reaction or product formed from a chemical indicator reacting with the analyte. In other optical systems, a chemical indicator fluoresces or emits light in response to the analyte when illuminated by an excitation beam. The light may be converted into an electrical output signal, such as current or potential, which may be similarly processed to the output signal from an electrochemical method. In either optical system, the biosensor measures and correlates the light with the analyte concentration of the sample.
[005] In electrochemical biosensors, the analyte concentration is determined from an electrical signal generated by an oxidation/reduction or redox reaction of the analyte or a species responsive to the analyte when an input signal is applied to the sample. The input signal may be applied as a single pulse or in multiple pulses, sequences, or cycles. An oxidoreductase, such as an enzyme or similar species, may be added to the sample to enhance the electron transfer from a first species to a second species during the redox reaction. The enzyme or similar species may react with a single analyte, thus providing specificity to a portion of the generated output signal. Examples of some specific oxidoreductases and corresponding analytes are given below in Table I.
Oxidoreductase (reagent layer) Analyte Glucose dehydrogenase [3-glucose Glucose oxidase [3-glucose
BACKGROUND
1002] Biosensors provide an analysis of a biological fluid, such as whole blood, serum, plasma, urine, saliva, interstitial, or intracellular fluid.
Typically, biosensors have a measurement device that analyzes a sample residing in a sensor strip. The sample usually is in liquid form and in addition to being a biological fluid, may be the derivative of a biological fluid, such as an extract, a dilution, a filtrate, or a reconstituted precipitate. The analysis performed by the biosensor determines the presence and/or concentration of one or more analytes, such as alcohol, glucose, uric acid, lactate, cholesterol, bilirubin, free fatty acids, triglycerides, proteins, ketones, phenylalanine or enzymes, in the biological fluid.
The analysis may be useful in the diagnosis and treatment of physiological abnormalities. For example, a diabetic individual may use a biosensor to determine the glucose level in whole blood for adjustments to diet and/or medication.
1003] Biosensors may be designed to analyze one or more analytes and may use different sample volumes. Some biosensors may analyze a single drop of whole blood, such as from 0.25-15 microliters (pL) in volume. Biosensors may be implemented using bench-top, portable, and like measurement devices. Portable measurement devices may be hand-held and allow for the identification and/or quantification of one or more analytes in a sample. Examples of portable measurement devices include the Ascensia Breeze and Elite meters of Bayer HealthCare in Tarrytown, New York, while examples of bench-top measurement devices include the Electrochemical Workstation available from CH Instruments in Austin, Texas. Biosensors providing shorter analysis times, while supplying the desired accuracy and/or precision, provide a substantial benefit to the user.
[004] Biosensors may use optical and/or electrochemical methods to analyze the sample. In some optical systems, the analyte concentration is determined by measuring light that has interacted with or been absorbed by a light-identifiable species, such as the analyte or a reaction or product formed from a chemical indicator reacting with the analyte. In other optical systems, a chemical indicator fluoresces or emits light in response to the analyte when illuminated by an excitation beam. The light may be converted into an electrical output signal, such as current or potential, which may be similarly processed to the output signal from an electrochemical method. In either optical system, the biosensor measures and correlates the light with the analyte concentration of the sample.
[005] In electrochemical biosensors, the analyte concentration is determined from an electrical signal generated by an oxidation/reduction or redox reaction of the analyte or a species responsive to the analyte when an input signal is applied to the sample. The input signal may be applied as a single pulse or in multiple pulses, sequences, or cycles. An oxidoreductase, such as an enzyme or similar species, may be added to the sample to enhance the electron transfer from a first species to a second species during the redox reaction. The enzyme or similar species may react with a single analyte, thus providing specificity to a portion of the generated output signal. Examples of some specific oxidoreductases and corresponding analytes are given below in Table I.
Oxidoreductase (reagent layer) Analyte Glucose dehydrogenase [3-glucose Glucose oxidase [3-glucose
- 2 -Oxidoreductase (reagent layer) Analyte Cholesterol esterase; cholesterol oxidase Cholesterol Lipoprotein lipase; glycerol kinase; glycerol-3- Triglycerides phosphate oxidase Lactate oxidase; lactate dehydrogenase; Lactate diaphorase Pyruvate oxidase Pyruvate Alcohol oxidase Alcohol Bilirubin oxidase Bilirubin Uricase Uric acid Glutathione reductase NAD(P)H
Carbon monoxide oxidoreductase Carbon monoxide Table I
[006] A mediator may be used to maintain the oxidation state of the enzyme.
Table II, below, provides some conventional combinations of enzymes and mediators for use with specific analytes.
Analyte Enzyme Mediator Glucose Glucose Oxidase Ferricyanide Glucose Glucose Dehydrogenase Ferricyanide Cholesterol Cholesterol Oxidase Ferricyanide Lactate Lactate Oxidase Ferricyanide Uric Acid Uricase Ferricyanide Alcohol Alcohol Oxidase Phenylenediamine Table II
Carbon monoxide oxidoreductase Carbon monoxide Table I
[006] A mediator may be used to maintain the oxidation state of the enzyme.
Table II, below, provides some conventional combinations of enzymes and mediators for use with specific analytes.
Analyte Enzyme Mediator Glucose Glucose Oxidase Ferricyanide Glucose Glucose Dehydrogenase Ferricyanide Cholesterol Cholesterol Oxidase Ferricyanide Lactate Lactate Oxidase Ferricyanide Uric Acid Uricase Ferricyanide Alcohol Alcohol Oxidase Phenylenediamine Table II
- 3 -[007] Electrochemical biosensors usually include a measurement device having electrical contacts that connect with electrical conductors in the sensor strip.
The conductors may be made from conductive materials, such as solid metals, metal pastes, conductive carbon, conductive carbon pastes, conductive polymers, and the like. The electrical conductors typically connect to working, counter, reference, and/or other electrodes that extend into a sample reservoir. One or more electrical conductors also may extend into the sample reservoir to provide functionality not provided by the electrodes.
[008] In many biosensors, the sensor strip may be adapted for use outside, inside, or partially inside a living organism. When used outside a living organism, a sample of the biological fluid is introduced into a sample reservoir in the sensor strip. The sensor strip may be placed in the measurement device before, after, or during the introduction of the sample for analysis. When inside or partially inside a living organism, the sensor strip may be continually immersed in the sample or the sample may be intermittently introduced to the strip. The sensor strip may include a reservoir that partially isolates a volume of the sample or be open to the sample.
Similarly, the sample may continuously flow through the strip or be interrupted for analysis.
[009] The measurement device applies an input signal through the electrical contacts to the electrical conductors of the sensor strip. The electrical conductors convey the input signal through the electrodes into the sample present in the sample reservoir. The redox reaction of the analyte generates an electrical output signal in response to the input signal. The electrical output signal from the strip may be a current (as generated by annperonnetry or voltannnnetry), a potential (as generated by potentionnetry/galvanonnetry), or an accumulated charge (as generated by coulonnetry). The measurement device may have the processing capability to measure and correlate the output signal with the presence and/or concentration of one or more analytes in the biological fluid.
The conductors may be made from conductive materials, such as solid metals, metal pastes, conductive carbon, conductive carbon pastes, conductive polymers, and the like. The electrical conductors typically connect to working, counter, reference, and/or other electrodes that extend into a sample reservoir. One or more electrical conductors also may extend into the sample reservoir to provide functionality not provided by the electrodes.
[008] In many biosensors, the sensor strip may be adapted for use outside, inside, or partially inside a living organism. When used outside a living organism, a sample of the biological fluid is introduced into a sample reservoir in the sensor strip. The sensor strip may be placed in the measurement device before, after, or during the introduction of the sample for analysis. When inside or partially inside a living organism, the sensor strip may be continually immersed in the sample or the sample may be intermittently introduced to the strip. The sensor strip may include a reservoir that partially isolates a volume of the sample or be open to the sample.
Similarly, the sample may continuously flow through the strip or be interrupted for analysis.
[009] The measurement device applies an input signal through the electrical contacts to the electrical conductors of the sensor strip. The electrical conductors convey the input signal through the electrodes into the sample present in the sample reservoir. The redox reaction of the analyte generates an electrical output signal in response to the input signal. The electrical output signal from the strip may be a current (as generated by annperonnetry or voltannnnetry), a potential (as generated by potentionnetry/galvanonnetry), or an accumulated charge (as generated by coulonnetry). The measurement device may have the processing capability to measure and correlate the output signal with the presence and/or concentration of one or more analytes in the biological fluid.
- 4 -[0010] In conventional amperonnetry, current is measured during a read pulse as a constant potential (voltage) is applied across the working and counter electrodes of the sensor strip. The measured current is used to quantify the analyte in the sample. Annperonnetry measures the rate at which an electrochemically active, thus measurable, species is being oxidized or reduced at or near the working electrode.
Many variations of the annperonnetric method for biosensors have been described, for example in U.S. Pat. Nos. 5,620,579; 5,653,863; 6,153,069; and 6,413,411.
[0011] A disadvantage of conventional annperonnetric methods is the non-steady-state nature of the current after a potential is applied. The rate of current change with respect to time is very fast initially and becomes slower as the analysis proceeds due to the changing nature of the underlying diffusion process. Until the consumption rate of the ionized measurable species at the electrode surface equals the diffusion rate, a steady-state current cannot be obtained. Thus, conventional annperonnetry methods that measure the current during the transient period before a steady-state condition is reached, may provide more inaccuracy than if the measurement is taken during a steady-state time period.
[0012] The measurement performance of a biosensor is defined in terms of accuracy and/or precision. Increases in accuracy and/or precision provide for an increase in measurement performance for the biosensor. Accuracy may be expressed in terms of bias of the biosensor's analyte reading in comparison to a reference analyte reading, with larger bias values representing less accuracy, while precision may be expressed in terms of the spread or variance among multiple analyte readings in relation to a mean. Bias is the difference between a value determined from the biosensor and the accepted reference value and may be expressed in terms of "absolute bias" or "relative bias". Absolute bias may be expressed in the units of the measurement, such as nng/dL, while relative bias may be expressed as a percentage of the absolute bias value over the reference value.
Many variations of the annperonnetric method for biosensors have been described, for example in U.S. Pat. Nos. 5,620,579; 5,653,863; 6,153,069; and 6,413,411.
[0011] A disadvantage of conventional annperonnetric methods is the non-steady-state nature of the current after a potential is applied. The rate of current change with respect to time is very fast initially and becomes slower as the analysis proceeds due to the changing nature of the underlying diffusion process. Until the consumption rate of the ionized measurable species at the electrode surface equals the diffusion rate, a steady-state current cannot be obtained. Thus, conventional annperonnetry methods that measure the current during the transient period before a steady-state condition is reached, may provide more inaccuracy than if the measurement is taken during a steady-state time period.
[0012] The measurement performance of a biosensor is defined in terms of accuracy and/or precision. Increases in accuracy and/or precision provide for an increase in measurement performance for the biosensor. Accuracy may be expressed in terms of bias of the biosensor's analyte reading in comparison to a reference analyte reading, with larger bias values representing less accuracy, while precision may be expressed in terms of the spread or variance among multiple analyte readings in relation to a mean. Bias is the difference between a value determined from the biosensor and the accepted reference value and may be expressed in terms of "absolute bias" or "relative bias". Absolute bias may be expressed in the units of the measurement, such as nng/dL, while relative bias may be expressed as a percentage of the absolute bias value over the reference value.
- 5 -Reference values may be obtained with a reference instrument, such as the YSI
STAT PLUSTM available from YSI Inc., Yellow Springs, Ohio.
[0013] Many biosensors include one or more methods to correct the error associated with an analysis. The concentration values obtained from an analysis with an error may be inaccurate. The ability to correct these inaccurate analyses may increase the accuracy of the concentration values obtained. An error correction system may compensate for one or more errors, such as sample hematocrit content, which is different from a reference sample. For example, conventional biosensors may be configured to report glucose concentrations presuming a 40`)/0 (v/v) hematocrit content for a whole blood sample, regardless of the actual hematocrit content of the sample. In these systems, any glucose measurement performed on a whole blood sample containing less or more than 40`)/0 hematocrit will include error or bias attributable to the "hematocrit effect".
[0014] In conventional biosensor sensor strips for determining glucose concentrations, glucose may be oxidized by an enzyme, which then transfers the electron to a mediator. This reduced mediator then travels to the working electrode where it is electrochemically oxidized. The amount of mediator being oxidized may be correlated to the current flowing between the working and counter electrodes of the sensor strip. Quantitatively, the current measured at the working electrode is directly proportional to the diffusion coefficient of the mediator. The hematocrit effect interferes with this process because the red blood cells block the diffusion of the mediator to the working electrode. Subsequently, the hematocrit effect influences the amount of current measured at the working electrode without any connection to the amount of glucose in the sample.
[0015] Hennatocrit bias refers to the difference between the reference glucose concentration obtained with a reference instrument and an experimental glucose reading obtained from a biosensor for samples containing differing hematocrit levels. The difference between the reference and values obtained from the
STAT PLUSTM available from YSI Inc., Yellow Springs, Ohio.
[0013] Many biosensors include one or more methods to correct the error associated with an analysis. The concentration values obtained from an analysis with an error may be inaccurate. The ability to correct these inaccurate analyses may increase the accuracy of the concentration values obtained. An error correction system may compensate for one or more errors, such as sample hematocrit content, which is different from a reference sample. For example, conventional biosensors may be configured to report glucose concentrations presuming a 40`)/0 (v/v) hematocrit content for a whole blood sample, regardless of the actual hematocrit content of the sample. In these systems, any glucose measurement performed on a whole blood sample containing less or more than 40`)/0 hematocrit will include error or bias attributable to the "hematocrit effect".
[0014] In conventional biosensor sensor strips for determining glucose concentrations, glucose may be oxidized by an enzyme, which then transfers the electron to a mediator. This reduced mediator then travels to the working electrode where it is electrochemically oxidized. The amount of mediator being oxidized may be correlated to the current flowing between the working and counter electrodes of the sensor strip. Quantitatively, the current measured at the working electrode is directly proportional to the diffusion coefficient of the mediator. The hematocrit effect interferes with this process because the red blood cells block the diffusion of the mediator to the working electrode. Subsequently, the hematocrit effect influences the amount of current measured at the working electrode without any connection to the amount of glucose in the sample.
[0015] Hennatocrit bias refers to the difference between the reference glucose concentration obtained with a reference instrument and an experimental glucose reading obtained from a biosensor for samples containing differing hematocrit levels. The difference between the reference and values obtained from the
- 6 -biosensor results from the varying hennatocrit levels between specific whole blood samples.
[0016] In addition to the hennatocrit effect, measurement inaccuracies also may arise when the measurable species concentration does not correlate with the analyte concentration. For example, when a sensor system determines the concentration of a reduced mediator generated in response to the oxidation of an analyte, any reduced mediator not generated by oxidation of the analyte will lead to the sensor system indicating that more analyte is present in the sample than is correct due to mediator background. Thus, "mediator background" is the bias introduced into the measured analyte concentration attributable to measurable species not responsive to the underlying analyte concentration.
[0017] In an attempt to overcome one or more of these disadvantages, conventional biosensors have attempted multiple techniques, not only with regard to the mechanical design of the sensor strip and reagent selection, but also regarding the manner in which the measurement device applies the electric potential to the strip. For example, conventional methods of reducing the hennatocrit effect for annperonnetric sensors include the use of filters, as disclosed in U.S. Pat.
Nos.
5,708,247 and 5,951,836; reversing the polarity of the applied current, as disclosed in WO 2001/57510; and by methods that maximize the inherent resistance of the sample.
[0018] Multiple methods of applying the input signal to the strip, commonly referred to as pulse methods, sequences, or cycles, have been used to address inaccuracies in the determined analyte concentration. For example, in U.S.
Pat. No.
4,897,162 the input signal includes a continuous application of rising and falling voltage potentials that are commingled to give a triangular-shaped wave.
Furthermore, WO 2004/053476 and U.S. Pat. Docs. 2003/0178322 and 2003/0113933 describe input signals that include the continuous application of rising and falling voltage potentials that also change polarity.
[0016] In addition to the hennatocrit effect, measurement inaccuracies also may arise when the measurable species concentration does not correlate with the analyte concentration. For example, when a sensor system determines the concentration of a reduced mediator generated in response to the oxidation of an analyte, any reduced mediator not generated by oxidation of the analyte will lead to the sensor system indicating that more analyte is present in the sample than is correct due to mediator background. Thus, "mediator background" is the bias introduced into the measured analyte concentration attributable to measurable species not responsive to the underlying analyte concentration.
[0017] In an attempt to overcome one or more of these disadvantages, conventional biosensors have attempted multiple techniques, not only with regard to the mechanical design of the sensor strip and reagent selection, but also regarding the manner in which the measurement device applies the electric potential to the strip. For example, conventional methods of reducing the hennatocrit effect for annperonnetric sensors include the use of filters, as disclosed in U.S. Pat.
Nos.
5,708,247 and 5,951,836; reversing the polarity of the applied current, as disclosed in WO 2001/57510; and by methods that maximize the inherent resistance of the sample.
[0018] Multiple methods of applying the input signal to the strip, commonly referred to as pulse methods, sequences, or cycles, have been used to address inaccuracies in the determined analyte concentration. For example, in U.S.
Pat. No.
4,897,162 the input signal includes a continuous application of rising and falling voltage potentials that are commingled to give a triangular-shaped wave.
Furthermore, WO 2004/053476 and U.S. Pat. Docs. 2003/0178322 and 2003/0113933 describe input signals that include the continuous application of rising and falling voltage potentials that also change polarity.
- 7 -[0019] Other conventional methods combine a specific electrode configuration with a input signal adapted to that configuration. For example, U.S.
Pat. No. 5,942,102 combines the specific electrode configuration provided by a thin layer cell with a continuous pulse so that the reaction products from the counter electrode arrive at the working electrode. This combination is used to drive the reaction until the current change verses time becomes constant, thus reaching a true steady state condition for the mediator moving between the working and counter electrodes during the potential step. While each of these methods balances various advantages and disadvantages, none are ideal.
[0020] As may be seen from the above description, there is an ongoing need for improved biosensors, especially those that may provide an increasingly accurate determination of the analyte concentration in less time. The systems, devices, and methods of the present invention overcome at least one of the disadvantages associated with conventional systems.
SUMMARY
[0021] A method for determining the concentration of an analyte in a sample is provided that includes applying an input signal to the sample, the input signal including at least 3 duty cycles within 180 seconds, where each duty cycle includes an excitation pulse and a relaxation. An output signal responsive to a measurable species is measured within 300 milliseconds of applying the excitation pulse of at least one of the duty cycles. The concentration of the analyte in the sample is determined in response to the measured output signal. The duty cycles may each include an excitation at a fixed potential, during which a current may be recorded, and a relaxation. The pulse sequence may include a terminal read pulse and may be applied to a sensor strip including a diffusion barrier layer. The determined analyte concentration may include less bias attributable to mediator background than the same or another method lacking the output signal measurement within milliseconds. Through the use of transient current data, the concentration of the
Pat. No. 5,942,102 combines the specific electrode configuration provided by a thin layer cell with a continuous pulse so that the reaction products from the counter electrode arrive at the working electrode. This combination is used to drive the reaction until the current change verses time becomes constant, thus reaching a true steady state condition for the mediator moving between the working and counter electrodes during the potential step. While each of these methods balances various advantages and disadvantages, none are ideal.
[0020] As may be seen from the above description, there is an ongoing need for improved biosensors, especially those that may provide an increasingly accurate determination of the analyte concentration in less time. The systems, devices, and methods of the present invention overcome at least one of the disadvantages associated with conventional systems.
SUMMARY
[0021] A method for determining the concentration of an analyte in a sample is provided that includes applying an input signal to the sample, the input signal including at least 3 duty cycles within 180 seconds, where each duty cycle includes an excitation pulse and a relaxation. An output signal responsive to a measurable species is measured within 300 milliseconds of applying the excitation pulse of at least one of the duty cycles. The concentration of the analyte in the sample is determined in response to the measured output signal. The duty cycles may each include an excitation at a fixed potential, during which a current may be recorded, and a relaxation. The pulse sequence may include a terminal read pulse and may be applied to a sensor strip including a diffusion barrier layer. The determined analyte concentration may include less bias attributable to mediator background than the same or another method lacking the output signal measurement within milliseconds. Through the use of transient current data, the concentration of the
- 8 -analyte may be determined when a steady-state condition is not reached during the excitation pulses of the duty cycles of the input signal. A data treatment may be applied to the measured currents to determine the concentration of the analyte in the sample.
[0022] A handheld measurement device adapted to receive a sensor strip is provided for determining the concentration of an analyte in a sample. The device includes contacts, at least one display, and electronic circuitry establishing electrical communication between the contacts and the display. The circuitry includes an electric charger and a processor, where the processor is in electrical communication with a storage medium. The medium includes computer readable software code, which when executed by the processor, causes the charger to implement an input signal including at least 3 duty cycles within 180 seconds between the contacts.
Each duty cycle includes an excitation and a relaxation. The processor is operable to measure at least one current value at the at least two contacts within 300 milliseconds of the charger applying the excitation. The processor also is operable to determine the analyte in the biological fluid in response to the at least one current value.
[0023] A biosensor system for determining an analyte concentration in a sample is provided. The system includes a sensor strip having a sample interface adjacent to a reservoir formed by the strip, and a measurement device having a processor connected to a sensor interface. The sensor interface is in electrical communication with the sample interface, and the processor is in electrical communication with a storage medium. The processor determines an output signal value responsive to the concentration of the analyte in the sample from the sensor interface within 300 milliseconds of applying an excitation pulse to the sample interface. The excitation pulse is part of an input signal including at least 3 duty cycles within 10 seconds, each duty cycle including an excitation and a relaxation.
[0022] A handheld measurement device adapted to receive a sensor strip is provided for determining the concentration of an analyte in a sample. The device includes contacts, at least one display, and electronic circuitry establishing electrical communication between the contacts and the display. The circuitry includes an electric charger and a processor, where the processor is in electrical communication with a storage medium. The medium includes computer readable software code, which when executed by the processor, causes the charger to implement an input signal including at least 3 duty cycles within 180 seconds between the contacts.
Each duty cycle includes an excitation and a relaxation. The processor is operable to measure at least one current value at the at least two contacts within 300 milliseconds of the charger applying the excitation. The processor also is operable to determine the analyte in the biological fluid in response to the at least one current value.
[0023] A biosensor system for determining an analyte concentration in a sample is provided. The system includes a sensor strip having a sample interface adjacent to a reservoir formed by the strip, and a measurement device having a processor connected to a sensor interface. The sensor interface is in electrical communication with the sample interface, and the processor is in electrical communication with a storage medium. The processor determines an output signal value responsive to the concentration of the analyte in the sample from the sensor interface within 300 milliseconds of applying an excitation pulse to the sample interface. The excitation pulse is part of an input signal including at least 3 duty cycles within 10 seconds, each duty cycle including an excitation and a relaxation.
- 9 -[0024] A method of reducing the bias attributable to the hematocrit effect in a determined concentration of an analyte in a sample is provided that includes applying an input signal including at least 3 duty cycles within 180 seconds to the sample. The output signal from which the concentration of the analyte in the sample is determined is recorded within 300 milliseconds of applying an excitation pulse.
[0024a] In another embodiment of the present invention there is provided a method, comprising: applying an input signal to a sample, where the input signal has at least 3 duty cycles within 10 seconds, and where each of the at least 3 duty cycles includes an excitation pulse and a relaxation;
measuring an output signal responsive to a measurable species within 300 milliseconds of an excitation pulse of at least one duty cycle; and determining a concentration of an analyte in the sample in response to the measured output signal.
[0024b] In a further embodiment of the present invention there is provided a method of reducing bias in a determined =concentration of an analyte in a sample, comprising: applying an input signal to the sample, where the input signal has at least 3 duty cycles within 10 seconds, and where each of the at least 3 duty cycles comprises an excitation pulse and a relaxation; measuring an output signal responsive to a measurable species within 300 milliseconds of an excitation pulse of at least one of the at least 3 duty cycles; and determining a concentration of the analyte in the sample in response to the measured output signal.
[0024c] In yet another embodiment of the present invention
[0024a] In another embodiment of the present invention there is provided a method, comprising: applying an input signal to a sample, where the input signal has at least 3 duty cycles within 10 seconds, and where each of the at least 3 duty cycles includes an excitation pulse and a relaxation;
measuring an output signal responsive to a measurable species within 300 milliseconds of an excitation pulse of at least one duty cycle; and determining a concentration of an analyte in the sample in response to the measured output signal.
[0024b] In a further embodiment of the present invention there is provided a method of reducing bias in a determined =concentration of an analyte in a sample, comprising: applying an input signal to the sample, where the input signal has at least 3 duty cycles within 10 seconds, and where each of the at least 3 duty cycles comprises an excitation pulse and a relaxation; measuring an output signal responsive to a measurable species within 300 milliseconds of an excitation pulse of at least one of the at least 3 duty cycles; and determining a concentration of the analyte in the sample in response to the measured output signal.
[0024c] In yet another embodiment of the present invention
- 10 -there is provided a handheld measurement device, comprising:
a sensor interface adapted to receive a sensor strip, the sensor interface including at least two contacts; at least one display; and electronic circuitry establishing electrical communication between the at least two contacts and the display, where the electronic circuitry includes a signal generator and a processor in electrical communication, where the processor is in electrical communication with a storage medium having computer readable software code, where the processor is programmed to cause the signal generator to provide an input signal between the at least two contacts, where the input signal has at least 3 duty cycles within 10 seconds, where each of the at least 3 duty cycles includes an excitation pulse and a relaxation, where the processor is =programmed to Measure at least one current value at the at least two contacts within 300 milliseconds of the signal generator applying an excitation pulse having a pulse width from 0.3 to 0.8 second of at least one duty cycle of the at least 3 duty cycles, and where the processor is programmed to determine an analyte concentration in a biological fluid or a derivative of a biological fluid in response to the at least one current value.
[0024d] In yet a further embodiment of the present invention there is provided a biosensor system, comprising: a sensor strip having a sample interface adjacent to a reservoir formed by the sensor strip; and a measurement device having a processor connected to= a sensor interface, where the sensor interface has electrical communication with the sample interface, where the processor has electrical communication with a storage medium, where the processor is programmed to determine an output signal value responsive to the = - 10a -concentration of an analyte in a sample from the sensor interface within 300 milliseconds of applying an excitation pulse having a pulse width from 0.3 to 0.8 second to the sample interface, and where the excitation pulse is part of an input signal having at least 3 duty cycles within 10 seconds, where each duty cycle includes an excitation pulse and a relaxation.
[0024e] In another embodiment of the present invention there is provided a method, comprising: applying an input signal to a sample, wherein the input signal has at least 3 duty cycles within 30 seconds, and wherein each of the at least 3 duty cycles includes an excitation pulse and a relaxation;
=measuring an output signal responsive to a measurable species within 300 milliseconds from the start of an excitation pulse of at least one of the at least 3 duty cycles, wherein a pulse width of the excitation pulse is from 0.1 to 2 seconds; and determining a concentration of an analyte in the sample in response to the measured output signal.
BRIEF DESCRIPTION OF THE DRAWINGS
[0025] The invention may be better understood with reference to the following drawings and description. The components in the figures are not necessarily to scale, emphasis instead being placed upon illustrating the principles of the invention.
[0026] FIG. 1 represents an electrochemical analytic method for determining the presence and/or concentration of an analyte in a sample.
- 10b [0027] FIG. 2 is a graph illustrating the output signals generated from a gated amperometric input signal.
=[0028] FIG. 3A shows the hematocrit bias present in analyte concentration values determined from each of the three current values measured from each of the seven pulses represented in FIG. 2.
[0029] FIG. 3B shows the hematocrit bias span for samples including 50, 100, and 400 mg/dL glucose.
[0030] FIG. 4 shows the hematocrit bias for the first and third current values from P5 in FIG. 3A for multiple whole blood samples.
[0031] FIG. 5 depicts a schematic representation of a biosensor that determines an analyte concentration in a =sample.
- 10c -DETAILED DESCRIPTION
[0032] In WO 2007/013915, entitled "Gated Annperonnetry", pulsed input signals are used to analyze analytes in samples. The input signals include alternating excitation and relaxation periods. The present invention relates to a system and method of analyzing the output signals from the pulsed input signals to reduce bias, such as that arising from mediator background and the hennatocrit effect. By correlating output signal values measured within 300 ms of the initiation of an excitation pulse, the accuracy and/or precision of the analysis may be improved.
[0033] FIG. 1 represents an electrochemical analysis 100 for determining the presence and/or concentration of an analyte in a sample. In 110, the sample is introduced to the biosensor. In 120, a portion of the analyte in the sample undergoes a redox reaction. In 130, electrons are optionally transferred from the analyte to a mediator. In 140, a measurable species is electrochemically excited with an input signal. In 150, an output signal is generated and measured. In 160, the sample is allowed to relax, and in 170, additional excitation pulses are input.
In 180, the presence and/or concentration of the sample is determined from the output signal, and in 190, the concentration may be displayed, stored, or the like.
[0034] In 110, the sample is introduced to the sensor portion of the biosensor, such as a sensor strip. The sensor strip includes at least one working and at least one counter electrode. The electrodes may include one or more reagent layers. The working electrode may include a diffusion barrier layer that is integral to a reagent layer or that is distinct from the reagent layer. When the working electrode includes a distinct diffusion barrier layer, the reagent layer may or may not be disposed on the diffusion barrier layer.
[0035] A diffusion barrier layer provides a porous space having an internal volume where a measurable species may reside. The pores of the diffusion barrier
a sensor interface adapted to receive a sensor strip, the sensor interface including at least two contacts; at least one display; and electronic circuitry establishing electrical communication between the at least two contacts and the display, where the electronic circuitry includes a signal generator and a processor in electrical communication, where the processor is in electrical communication with a storage medium having computer readable software code, where the processor is programmed to cause the signal generator to provide an input signal between the at least two contacts, where the input signal has at least 3 duty cycles within 10 seconds, where each of the at least 3 duty cycles includes an excitation pulse and a relaxation, where the processor is =programmed to Measure at least one current value at the at least two contacts within 300 milliseconds of the signal generator applying an excitation pulse having a pulse width from 0.3 to 0.8 second of at least one duty cycle of the at least 3 duty cycles, and where the processor is programmed to determine an analyte concentration in a biological fluid or a derivative of a biological fluid in response to the at least one current value.
[0024d] In yet a further embodiment of the present invention there is provided a biosensor system, comprising: a sensor strip having a sample interface adjacent to a reservoir formed by the sensor strip; and a measurement device having a processor connected to= a sensor interface, where the sensor interface has electrical communication with the sample interface, where the processor has electrical communication with a storage medium, where the processor is programmed to determine an output signal value responsive to the = - 10a -concentration of an analyte in a sample from the sensor interface within 300 milliseconds of applying an excitation pulse having a pulse width from 0.3 to 0.8 second to the sample interface, and where the excitation pulse is part of an input signal having at least 3 duty cycles within 10 seconds, where each duty cycle includes an excitation pulse and a relaxation.
[0024e] In another embodiment of the present invention there is provided a method, comprising: applying an input signal to a sample, wherein the input signal has at least 3 duty cycles within 30 seconds, and wherein each of the at least 3 duty cycles includes an excitation pulse and a relaxation;
=measuring an output signal responsive to a measurable species within 300 milliseconds from the start of an excitation pulse of at least one of the at least 3 duty cycles, wherein a pulse width of the excitation pulse is from 0.1 to 2 seconds; and determining a concentration of an analyte in the sample in response to the measured output signal.
BRIEF DESCRIPTION OF THE DRAWINGS
[0025] The invention may be better understood with reference to the following drawings and description. The components in the figures are not necessarily to scale, emphasis instead being placed upon illustrating the principles of the invention.
[0026] FIG. 1 represents an electrochemical analytic method for determining the presence and/or concentration of an analyte in a sample.
- 10b [0027] FIG. 2 is a graph illustrating the output signals generated from a gated amperometric input signal.
=[0028] FIG. 3A shows the hematocrit bias present in analyte concentration values determined from each of the three current values measured from each of the seven pulses represented in FIG. 2.
[0029] FIG. 3B shows the hematocrit bias span for samples including 50, 100, and 400 mg/dL glucose.
[0030] FIG. 4 shows the hematocrit bias for the first and third current values from P5 in FIG. 3A for multiple whole blood samples.
[0031] FIG. 5 depicts a schematic representation of a biosensor that determines an analyte concentration in a =sample.
- 10c -DETAILED DESCRIPTION
[0032] In WO 2007/013915, entitled "Gated Annperonnetry", pulsed input signals are used to analyze analytes in samples. The input signals include alternating excitation and relaxation periods. The present invention relates to a system and method of analyzing the output signals from the pulsed input signals to reduce bias, such as that arising from mediator background and the hennatocrit effect. By correlating output signal values measured within 300 ms of the initiation of an excitation pulse, the accuracy and/or precision of the analysis may be improved.
[0033] FIG. 1 represents an electrochemical analysis 100 for determining the presence and/or concentration of an analyte in a sample. In 110, the sample is introduced to the biosensor. In 120, a portion of the analyte in the sample undergoes a redox reaction. In 130, electrons are optionally transferred from the analyte to a mediator. In 140, a measurable species is electrochemically excited with an input signal. In 150, an output signal is generated and measured. In 160, the sample is allowed to relax, and in 170, additional excitation pulses are input.
In 180, the presence and/or concentration of the sample is determined from the output signal, and in 190, the concentration may be displayed, stored, or the like.
[0034] In 110, the sample is introduced to the sensor portion of the biosensor, such as a sensor strip. The sensor strip includes at least one working and at least one counter electrode. The electrodes may include one or more reagent layers. The working electrode may include a diffusion barrier layer that is integral to a reagent layer or that is distinct from the reagent layer. When the working electrode includes a distinct diffusion barrier layer, the reagent layer may or may not be disposed on the diffusion barrier layer.
[0035] A diffusion barrier layer provides a porous space having an internal volume where a measurable species may reside. The pores of the diffusion barrier
-11 -layer may be selected so that the measurable species may diffuse into the diffusion barrier layer, while physically larger sample constituents, such as red blood cells, are substantially excluded. Although conventional sensor strips have used various materials to filter red blood cells from the surface of the working electrode, a diffusion barrier layer provides an internal porous space to contain and isolate a portion of the measurable species from the sample. A more detailed treatment of diffusion barrier layers may be found in U.S. Pub. No. 2007/0246357.
[0036] In 120 of FIG. 1, a portion of the analyte present in the sample is chemically or biochemically oxidized or reduced, such as by an oxidoreductase.
This occurs as the sample hydrates the reagents. Upon oxidation or reduction, electrons optionally may be transferred between the analyte and a mediator in 130.
Thus, an ionized measurable species is formed, such as from the analyte or a mediator. It may be beneficial to provide an initial time delay, or "incubation period," for the reagents to react with the analyte. Preferably, the initial time delay may be from 1 to 10 seconds. A more detailed treatment of initial time delays may be found in U.S. Pat. Nos. 5,620,579 and 5,653,863.
[0037] In 140 of FIG. 1, a measurable species, which may be the charged analyte from 120 or the charged mediator from 130, is electrochemically excited (oxidized or reduced) with an input signal. Input signals may be electrical signals, such as current or potential, that pulse or turn on and off at a set sequence.
The input signal is a sequence of excitation pulses separated by relaxations.
During an annperonnetric pulse, the electrical potential applied during the excitation is preferably applied at a substantially constant voltage and polarity throughout its duration. This directly contrasts to some conventional excitations where the voltage is changed or "swept" through multiple voltage potentials and/or polarities during data recordation.
[0038] During a relaxation, the electrical signal is off. Off includes time periods when an electrical signal is not present and preferably does not include time
[0036] In 120 of FIG. 1, a portion of the analyte present in the sample is chemically or biochemically oxidized or reduced, such as by an oxidoreductase.
This occurs as the sample hydrates the reagents. Upon oxidation or reduction, electrons optionally may be transferred between the analyte and a mediator in 130.
Thus, an ionized measurable species is formed, such as from the analyte or a mediator. It may be beneficial to provide an initial time delay, or "incubation period," for the reagents to react with the analyte. Preferably, the initial time delay may be from 1 to 10 seconds. A more detailed treatment of initial time delays may be found in U.S. Pat. Nos. 5,620,579 and 5,653,863.
[0037] In 140 of FIG. 1, a measurable species, which may be the charged analyte from 120 or the charged mediator from 130, is electrochemically excited (oxidized or reduced) with an input signal. Input signals may be electrical signals, such as current or potential, that pulse or turn on and off at a set sequence.
The input signal is a sequence of excitation pulses separated by relaxations.
During an annperonnetric pulse, the electrical potential applied during the excitation is preferably applied at a substantially constant voltage and polarity throughout its duration. This directly contrasts to some conventional excitations where the voltage is changed or "swept" through multiple voltage potentials and/or polarities during data recordation.
[0038] During a relaxation, the electrical signal is off. Off includes time periods when an electrical signal is not present and preferably does not include time
- 12 -periods when an electrical signal is present but has essentially no amplitude.
The electrical signal may switch between on and off by closing and opening an electrical circuit, respectively. The electrical circuit may be opened and closed mechanically, electrically, or by other methods.
[0039] Input signals may have one or more pulse interval. A pulse interval is the sum of a pulse and the relaxation constituting a duty cycle. Each pulse has an amplitude and a width. The amplitude indicates the intensity of the potential, the current, or the like of the electrical signal. The amplitude may vary or be substantially constant, such as during annperonnetry, during the pulse. The pulse width is the time duration of the pulse. The pulse widths in an input signal may vary or be substantially the same. Each relaxation has a relaxation width, which is the time duration of the relaxation. The relaxation widths in an input signal may vary or be substantially the same.
[0040] By adjusting the width of the excitation and relaxation of the duty cycles, gated input signals may increase the accuracy and/or precision of the analysis. While not wishing to be bound by any particular theory, this increase in accuracy and/or precision may result from drawing the measurable species excited at the working electrode from the interior of a diffusion barrier layer. As opposed to measurable species external to the diffusion barrier layer, which may have a varying rate of diffusion due to red blood cells and other sample constituents, measurable species within the diffusion barrier layer may have a relatively constant diffusion rate to the conductor. For example, and as described in U.S. Pub. No. 2007/0246357, entitled "Concentration Determination in a Diffusion Barrier Layer," a pulse width may be selected to substantially limit measurable species excitation to a diffusion barrier layer.
[0041] Preferable input signals include at least 3, 4, 6, 8, or 10 duty cycles applied during less than 30, 10, or 5 seconds. More preferably, at least 3 duty cycles are applied within 10 seconds. Input signals including at least 4 duty cycles
The electrical signal may switch between on and off by closing and opening an electrical circuit, respectively. The electrical circuit may be opened and closed mechanically, electrically, or by other methods.
[0039] Input signals may have one or more pulse interval. A pulse interval is the sum of a pulse and the relaxation constituting a duty cycle. Each pulse has an amplitude and a width. The amplitude indicates the intensity of the potential, the current, or the like of the electrical signal. The amplitude may vary or be substantially constant, such as during annperonnetry, during the pulse. The pulse width is the time duration of the pulse. The pulse widths in an input signal may vary or be substantially the same. Each relaxation has a relaxation width, which is the time duration of the relaxation. The relaxation widths in an input signal may vary or be substantially the same.
[0040] By adjusting the width of the excitation and relaxation of the duty cycles, gated input signals may increase the accuracy and/or precision of the analysis. While not wishing to be bound by any particular theory, this increase in accuracy and/or precision may result from drawing the measurable species excited at the working electrode from the interior of a diffusion barrier layer. As opposed to measurable species external to the diffusion barrier layer, which may have a varying rate of diffusion due to red blood cells and other sample constituents, measurable species within the diffusion barrier layer may have a relatively constant diffusion rate to the conductor. For example, and as described in U.S. Pub. No. 2007/0246357, entitled "Concentration Determination in a Diffusion Barrier Layer," a pulse width may be selected to substantially limit measurable species excitation to a diffusion barrier layer.
[0041] Preferable input signals include at least 3, 4, 6, 8, or 10 duty cycles applied during less than 30, 10, or 5 seconds. More preferably, at least 3 duty cycles are applied within 10 seconds. Input signals including at least 4 duty cycles
- 13 -applied in less than 7 seconds are especially preferred at present.
Preferably, the width of each excitation pulse is independently selected from between 0.1 and seconds and more preferably from between 0.2 and 1 second. At present, especially preferred input signal pulse widths are independently selected from between 0.3 and 0.8 seconds. Preferable pulse intervals are in the range of less than 3, 2.5, or 1.5 seconds. At present, input signals having pulse widths of 0.3 to 0.5 second and pulse intervals from 0.7 to 2 seconds are especially preferred. The input signal may have other pulse widths and intervals.
[0042] In 150 of FIG. 1, the biosensor generates an output signal in response to the measurable species and the input signal. The output signal, such as one or more current values, may be measured continuously or intermittently and may be recorded as a function of time. Output signals may include those that decline initially, those that increase and then decline, those that reach a steady-state, and those that are transient. Steady-state currents are observed when the current change with respect to time is substantially constant, such as within +10 or +5%.
Instead of conventional steady-state or slowly decaying currents, transient (rapidly decaying) current values may be obtained from pulsed input signals.
[0043] FIG.
2 is a graph illustrating the output signals generated from a gated annperonnetric input signal. When plotted as a function of time, each excitation pulse results in a transient decay profile having an initial high current value that decays. The input signal applied by the biosensor included eight pulses and seven relaxations, for a total of seven duty cycles. FIG. 2 omits the first duty cycle and shows that the eighth pulse was not followed by a relaxation. The pulses were applied at about 200 mV and had a pulse width of about 0.4 seconds. The pulse interval for the duty cycles was about 1.4 seconds, providing relaxation widths of about 1 second. The relaxations were provided by an open circuit. While square-wave pulses were used, other wave types compatible with the sensor system and the test sample also may be used.
Preferably, the width of each excitation pulse is independently selected from between 0.1 and seconds and more preferably from between 0.2 and 1 second. At present, especially preferred input signal pulse widths are independently selected from between 0.3 and 0.8 seconds. Preferable pulse intervals are in the range of less than 3, 2.5, or 1.5 seconds. At present, input signals having pulse widths of 0.3 to 0.5 second and pulse intervals from 0.7 to 2 seconds are especially preferred. The input signal may have other pulse widths and intervals.
[0042] In 150 of FIG. 1, the biosensor generates an output signal in response to the measurable species and the input signal. The output signal, such as one or more current values, may be measured continuously or intermittently and may be recorded as a function of time. Output signals may include those that decline initially, those that increase and then decline, those that reach a steady-state, and those that are transient. Steady-state currents are observed when the current change with respect to time is substantially constant, such as within +10 or +5%.
Instead of conventional steady-state or slowly decaying currents, transient (rapidly decaying) current values may be obtained from pulsed input signals.
[0043] FIG.
2 is a graph illustrating the output signals generated from a gated annperonnetric input signal. When plotted as a function of time, each excitation pulse results in a transient decay profile having an initial high current value that decays. The input signal applied by the biosensor included eight pulses and seven relaxations, for a total of seven duty cycles. FIG. 2 omits the first duty cycle and shows that the eighth pulse was not followed by a relaxation. The pulses were applied at about 200 mV and had a pulse width of about 0.4 seconds. The pulse interval for the duty cycles was about 1.4 seconds, providing relaxation widths of about 1 second. The relaxations were provided by an open circuit. While square-wave pulses were used, other wave types compatible with the sensor system and the test sample also may be used.
-14-[0044] The biosensor measured the output signal intermittently during each pulse in FIG. 2 and recorded three current values in a memory device. The output signal values were recorded at about 125 millisecond (ms) intervals starting about 125 ms after the initiation of each pulse. The intervals between successive recordings may be the same or different. In FIG. 2, three current values from the output signal were recorded and labeled with the letter I, showing the pulse number and measurement number by subscript. Thus, the third current value measured for the fifth pulse is labeled as [0045] FIG. 3A shows the hennatocrit bias present in analyte concentration values determined from each of the three current values measured from each of the seven pulses shown in FIG. 2, with larger hennatocrit error represented by larger absolute numerical values on the Y-axis. For each pulse, the first current value showed the least hennatocrit bias of the three values, with the bias difference between the first and third values becoming larger with each successive pulse.
Lower average hennatocrit bias across the measured currents also was observed for each successive pulse; however, each additional pulse prolonged the length of the analysis. Thus, while the current values from P8 included almost no hennatocrit error, the first current value from P5 may provide a preferred balance between hennatocrit error and analysis time. Also of interest is that the first current value measured for P5 had about the same hennatocrit error as the third current value from P8, taken more than 3 seconds later. These results establish that current values measured earlier in the pulse width include the least hennatocrit error.
[0046] FIG. 3B shows the hennatocrit bias span for samples including 50, 100, and 400 nng/dL glucose, with larger span values on the Y-axis representing larger hematocrit error. As in FIG. 3A, the first current value showed the least hennatocrit bias of the four current values measured during each pulse, with the bias difference between the first and fourth values becoming larger with each successive pulse. The unexpectedly lower hennatocrit bias in the first current value measured for each
Lower average hennatocrit bias across the measured currents also was observed for each successive pulse; however, each additional pulse prolonged the length of the analysis. Thus, while the current values from P8 included almost no hennatocrit error, the first current value from P5 may provide a preferred balance between hennatocrit error and analysis time. Also of interest is that the first current value measured for P5 had about the same hennatocrit error as the third current value from P8, taken more than 3 seconds later. These results establish that current values measured earlier in the pulse width include the least hennatocrit error.
[0046] FIG. 3B shows the hennatocrit bias span for samples including 50, 100, and 400 nng/dL glucose, with larger span values on the Y-axis representing larger hematocrit error. As in FIG. 3A, the first current value showed the least hennatocrit bias of the four current values measured during each pulse, with the bias difference between the first and fourth values becoming larger with each successive pulse. The unexpectedly lower hennatocrit bias in the first current value measured for each
- 15 -pulse was more pronounced at the higher 400 nng/dL glucose concentration level.
Thus, the accuracy improvement obtained from current measurements taken early in the decay increased as the glucose concentration of the whole blood samples increased.
[0047] FIG. 4 shows the hennatocrit bias for the first and third current values from P5 in FIG. 3A for multiple whole blood samples including varying hennatocrit and glucose content. The first current value i5,1 showed an IV correlation of 0.18, while the third current value i5,3 showed an IV correlation of 0.08, a greater than 50`)/0 reduction. The improved analyte concentration accuracy obtained from current values taken earlier in the decay is unexpected and directly contrasts with prior teachings that accuracy is achieved from measurements taken in the later steady-state portion of a decay. These results counterintuitively establish that improved accuracy and/or precision may be obtained from measurements taken early in the rapidly changing transient portion of the decay.
[0048] Preferably, the output current value from which the analyte concentration is determined is measured within less than 300 ms of applying the excitation pulse. More preferably, the output current value used to determine the analyte concentration of the sample is measured within less than 175 ms from applying an excitation pulse or within 10 to 150 ms of applying the pulse.
More preferably still, the output current value from which concentration is determined is measured within 30 to 150 ms of applying an excitation pulse. At present, determining the concentration of the analyte from an output current value measured within 60 to 150 ms of applying an excitation pulse is especially preferred.
Preferably, the pulse from which the analytic output current value is measured to determine the concentration of the analyte in the sample is applied within 11 seconds or less of applying the initial excitation pulse and is more preferably applied within 7 seconds or less applying the initial pulse.
Thus, the accuracy improvement obtained from current measurements taken early in the decay increased as the glucose concentration of the whole blood samples increased.
[0047] FIG. 4 shows the hennatocrit bias for the first and third current values from P5 in FIG. 3A for multiple whole blood samples including varying hennatocrit and glucose content. The first current value i5,1 showed an IV correlation of 0.18, while the third current value i5,3 showed an IV correlation of 0.08, a greater than 50`)/0 reduction. The improved analyte concentration accuracy obtained from current values taken earlier in the decay is unexpected and directly contrasts with prior teachings that accuracy is achieved from measurements taken in the later steady-state portion of a decay. These results counterintuitively establish that improved accuracy and/or precision may be obtained from measurements taken early in the rapidly changing transient portion of the decay.
[0048] Preferably, the output current value from which the analyte concentration is determined is measured within less than 300 ms of applying the excitation pulse. More preferably, the output current value used to determine the analyte concentration of the sample is measured within less than 175 ms from applying an excitation pulse or within 10 to 150 ms of applying the pulse.
More preferably still, the output current value from which concentration is determined is measured within 30 to 150 ms of applying an excitation pulse. At present, determining the concentration of the analyte from an output current value measured within 60 to 150 ms of applying an excitation pulse is especially preferred.
Preferably, the pulse from which the analytic output current value is measured to determine the concentration of the analyte in the sample is applied within 11 seconds or less of applying the initial excitation pulse and is more preferably applied within 7 seconds or less applying the initial pulse.
- 16-[0049] In 160 of FIG. 1, the sample undergoes relaxation. The measurement device may open the circuit through the sensor strip, thus allowing relaxation.
During the relaxation 160, the current present during the excitation 140 is substantially reduced by at least one-half, preferably by an order of magnitude, and more preferably to zero. Preferably, a zero current state is provided by an open circuit or other method known to those of ordinary skill in the art to provide a substantially zero current flow. Preferably, the output signal is not recorded during the relaxation 160.
[0050] During the relaxation 160, an ionizing agent, such as an oxidoreductase, may react with the analyte to generate additional measurable species without the effects of an electric potential. For example, a glucose biosensor including glucose oxidase and a ferricyanide mediator as reagents will produce additional ferrocyanide (reduced mediator) responsive to the analyte concentration of the sample without interference from an electric potential during the relaxation 160.
[0051] In 170 of FIG. 1, the biosensor continues to apply pulses from the input signal to the working and counter electrodes for the desired time period. The duty cycle including the excitation 140 and the relaxation 160 may be repeated or a duty cycle having different pulse widths and/or intervals may be applied.
[0052] In 180 of FIG. 1, the biosensor analyzes the output signal value recorded within 300 ms of applying a pulse to determine the concentration of the analyte in the sample. Additional current, time, and/or other values also may be analyzed. In 190, the analyte concentration value may be displayed, stored for future reference, and/or used for additional calculations.
[0053] FIG. 5 depicts a schematic representation of a biosensor 500 that determines an analyte concentration in a sample of a biological fluid using a pulsed input signal. Biosensor 500 includes a measurement device 502 and a sensor strip 504, which may be implemented in any analytical instrument, including a bench-top device, a portable or hand-held device, or the like. The biosensor 500 may be utilized to determine analyte concentrations, including those of glucose, uric acid, lactate, cholesterol, bilirubin, and the like. While a particular configuration is shown, the biosensor 500 may have other configurations, including those with additional components.
[0054] The sensor strip 504 has a base 506 that forms a reservoir 508 and a channel 510 with an opening 1212. The reservoir 508 and the channel 510 may be covered by a lid with a vent. The reservoir 508 defines a partially-enclosed volume.
The reservoir 508 may contain a composition that assists in retaining a liquid sample such as water-swellable polymers or porous polymer matrices. Reagents may be deposited in the reservoir 508 and/or channel 510. The reagents may include one or more enzymes, binders, mediators, and like species. The sensor strip 504 also may have a sample interface 514 disposed adjacent to the reservoir 508. The sample interface 514 may partially or completely surround the reservoir 508.
The sensor strip 504 may have other configurations.
[0055] The sample interface 514 has conductors connected to a working electrode and a counter electrode. The electrodes may be substantially in the same plane or in more than one plane. Other separation distances between the electrodes and the lid may be used. The electrodes may be disposed on a surface of the base 506 that forms the reservoir 508. The electrodes may extend or project into the reservoir 508. A dielectric layer may partially cover the conductors and/or the electrodes. The sample interface 514 may have other electrodes and conductors.
[0056] The measurement device 502 includes electrical circuitry 516 connected to a sensor interface 518 and a display 520. The electrical circuitry 516 includes a processor 522 connected to a signal generator 524, an optional temperature sensor 526, and a storage medium 528.
[0057] The signal generator 524 provides an electrical input signal to the sensor interface 518 in response to the processor 522. The electrical input signal may be transmitted by the sensor interface 518 to the sample interface 514 to apply the electrical input signal to the sample of the biological fluid. The electrical input signal may be a potential or current and may be constant, variable, or a combination thereof, such as when an AC signal is applied with a DC signal offset. The electrical input signal may be applied as a single pulse or in multiple pulses, sequences, or cycles. The signal generator 524 also may record an output signal from the sensor interface as a generator-recorder.
[0058] The optional temperature sensor 526 determines the temperature of the sample in the reservoir of the sensor strip 504. The temperature of the sample may be measured, calculated from the output signal, or assumed to be the same or similar to a measurement of the ambient temperature or the temperature of a device implementing the biosensor system. The temperature may be measured using a thernnister, thermometer, or other temperature sensing device. Other techniques may be used to determine the sample temperature.
[0059] The storage medium 528 may be a magnetic, optical, or semiconductor memory, another storage device, or the like. The storage medium 528 may be a fixed memory device, a removable memory device, such as a memory card, remotely accessed, or the like.
[0060] The processor 522 implements the analyte analysis and data treatment using computer readable software code and data stored in the storage medium 528.
The processor 522 may start the analyte analysis in response to the presence of the sensor strip 504 at the sensor interface 518, the application of a sample to the sensor strip 504, in response to user input, or the like. The processor 522 directs the signal generator 524 to provide the electrical input signal to the sensor interface 518. The processor 522 may receive the sample temperature from the optional temperature sensor 526. The processor 522 receives the output signal from the sensor interface 518. The output signal is generated in response to the redox reaction of the analyte in the sample. The processor 522 measures the output signal within 300 ms of the application of an excitation pulse from the signal generator 524. The output signal is correlated with the analyte concentration of the sample using one or more correlation equations in the processor 522. The results of the analyte analysis may be output to the display 520 and may be stored in the storage medium 528.
[0061] The correlation equations relating analyte concentrations and output signals may be represented graphically, mathematically, a combination thereof, or the like. The correlation equations may be represented by a program number (PNA) table, another look-up table, or the like that is stored in the storage medium 528.
Instructions regarding implementation of the analyte analysis may be provided by the computer readable software code stored in the storage medium 528. The code may be object code or any other code describing or controlling the functionality described herein. The data from the analyte analysis may be subjected to one or more data treatments, including the determination of decay rates, K constants, ratios, and the like in the processor 522.
[0062] The sensor interface 518 has contacts that connect or electrically communicate with the conductors in the sample interface 514 of the sensor strip 504. The sensor interface 518 transmits the electrical input signal from the signal generator 524 through the contacts to the connectors in the sample interface 514.
The sensor interface 518 also transmits the output signal from the sample through the contacts to the processor 522 and/or signal generator 524.
[0063] The display 520 may be analog or digital. The display may be an LCD
display adapted to displaying a numerical reading.
[0064] In use, a liquid sample for analysis is transferred into the reservoir 508 by introducing the liquid to the opening 512. The liquid sample flows through the channel 510, filling the reservoir 508 while expelling the previously contained air.
The liquid sample chemically reacts with the reagents deposited in the channel and/or reservoir 508.
[0065] The sensor strip 502 is disposed adjacent to the measurement device 502. Adjacent includes positions where the sample interface 514 is in electrical and/or optical communication with the sensor interface 508. Electrical communication includes the transfer of input and/or output signals between contacts in the sensor interface 518 and conductors in the sample interface 514.
Optical communication includes the transfer of light between an optical portal in the sample interface 514 and a detector in the sensor interface 508. Optical communication also includes the transfer of light between an optical portal in the sample interface 502 and a light source in the sensor interface 508.
[0066] While various embodiments of the invention have been described, it will be apparent to those of ordinary skill in the art that other embodiments and implementations are possible within the scope of the invention. Accordingly, the invention is not to be restricted except in light of the attached claims and their equivalents.
During the relaxation 160, the current present during the excitation 140 is substantially reduced by at least one-half, preferably by an order of magnitude, and more preferably to zero. Preferably, a zero current state is provided by an open circuit or other method known to those of ordinary skill in the art to provide a substantially zero current flow. Preferably, the output signal is not recorded during the relaxation 160.
[0050] During the relaxation 160, an ionizing agent, such as an oxidoreductase, may react with the analyte to generate additional measurable species without the effects of an electric potential. For example, a glucose biosensor including glucose oxidase and a ferricyanide mediator as reagents will produce additional ferrocyanide (reduced mediator) responsive to the analyte concentration of the sample without interference from an electric potential during the relaxation 160.
[0051] In 170 of FIG. 1, the biosensor continues to apply pulses from the input signal to the working and counter electrodes for the desired time period. The duty cycle including the excitation 140 and the relaxation 160 may be repeated or a duty cycle having different pulse widths and/or intervals may be applied.
[0052] In 180 of FIG. 1, the biosensor analyzes the output signal value recorded within 300 ms of applying a pulse to determine the concentration of the analyte in the sample. Additional current, time, and/or other values also may be analyzed. In 190, the analyte concentration value may be displayed, stored for future reference, and/or used for additional calculations.
[0053] FIG. 5 depicts a schematic representation of a biosensor 500 that determines an analyte concentration in a sample of a biological fluid using a pulsed input signal. Biosensor 500 includes a measurement device 502 and a sensor strip 504, which may be implemented in any analytical instrument, including a bench-top device, a portable or hand-held device, or the like. The biosensor 500 may be utilized to determine analyte concentrations, including those of glucose, uric acid, lactate, cholesterol, bilirubin, and the like. While a particular configuration is shown, the biosensor 500 may have other configurations, including those with additional components.
[0054] The sensor strip 504 has a base 506 that forms a reservoir 508 and a channel 510 with an opening 1212. The reservoir 508 and the channel 510 may be covered by a lid with a vent. The reservoir 508 defines a partially-enclosed volume.
The reservoir 508 may contain a composition that assists in retaining a liquid sample such as water-swellable polymers or porous polymer matrices. Reagents may be deposited in the reservoir 508 and/or channel 510. The reagents may include one or more enzymes, binders, mediators, and like species. The sensor strip 504 also may have a sample interface 514 disposed adjacent to the reservoir 508. The sample interface 514 may partially or completely surround the reservoir 508.
The sensor strip 504 may have other configurations.
[0055] The sample interface 514 has conductors connected to a working electrode and a counter electrode. The electrodes may be substantially in the same plane or in more than one plane. Other separation distances between the electrodes and the lid may be used. The electrodes may be disposed on a surface of the base 506 that forms the reservoir 508. The electrodes may extend or project into the reservoir 508. A dielectric layer may partially cover the conductors and/or the electrodes. The sample interface 514 may have other electrodes and conductors.
[0056] The measurement device 502 includes electrical circuitry 516 connected to a sensor interface 518 and a display 520. The electrical circuitry 516 includes a processor 522 connected to a signal generator 524, an optional temperature sensor 526, and a storage medium 528.
[0057] The signal generator 524 provides an electrical input signal to the sensor interface 518 in response to the processor 522. The electrical input signal may be transmitted by the sensor interface 518 to the sample interface 514 to apply the electrical input signal to the sample of the biological fluid. The electrical input signal may be a potential or current and may be constant, variable, or a combination thereof, such as when an AC signal is applied with a DC signal offset. The electrical input signal may be applied as a single pulse or in multiple pulses, sequences, or cycles. The signal generator 524 also may record an output signal from the sensor interface as a generator-recorder.
[0058] The optional temperature sensor 526 determines the temperature of the sample in the reservoir of the sensor strip 504. The temperature of the sample may be measured, calculated from the output signal, or assumed to be the same or similar to a measurement of the ambient temperature or the temperature of a device implementing the biosensor system. The temperature may be measured using a thernnister, thermometer, or other temperature sensing device. Other techniques may be used to determine the sample temperature.
[0059] The storage medium 528 may be a magnetic, optical, or semiconductor memory, another storage device, or the like. The storage medium 528 may be a fixed memory device, a removable memory device, such as a memory card, remotely accessed, or the like.
[0060] The processor 522 implements the analyte analysis and data treatment using computer readable software code and data stored in the storage medium 528.
The processor 522 may start the analyte analysis in response to the presence of the sensor strip 504 at the sensor interface 518, the application of a sample to the sensor strip 504, in response to user input, or the like. The processor 522 directs the signal generator 524 to provide the electrical input signal to the sensor interface 518. The processor 522 may receive the sample temperature from the optional temperature sensor 526. The processor 522 receives the output signal from the sensor interface 518. The output signal is generated in response to the redox reaction of the analyte in the sample. The processor 522 measures the output signal within 300 ms of the application of an excitation pulse from the signal generator 524. The output signal is correlated with the analyte concentration of the sample using one or more correlation equations in the processor 522. The results of the analyte analysis may be output to the display 520 and may be stored in the storage medium 528.
[0061] The correlation equations relating analyte concentrations and output signals may be represented graphically, mathematically, a combination thereof, or the like. The correlation equations may be represented by a program number (PNA) table, another look-up table, or the like that is stored in the storage medium 528.
Instructions regarding implementation of the analyte analysis may be provided by the computer readable software code stored in the storage medium 528. The code may be object code or any other code describing or controlling the functionality described herein. The data from the analyte analysis may be subjected to one or more data treatments, including the determination of decay rates, K constants, ratios, and the like in the processor 522.
[0062] The sensor interface 518 has contacts that connect or electrically communicate with the conductors in the sample interface 514 of the sensor strip 504. The sensor interface 518 transmits the electrical input signal from the signal generator 524 through the contacts to the connectors in the sample interface 514.
The sensor interface 518 also transmits the output signal from the sample through the contacts to the processor 522 and/or signal generator 524.
[0063] The display 520 may be analog or digital. The display may be an LCD
display adapted to displaying a numerical reading.
[0064] In use, a liquid sample for analysis is transferred into the reservoir 508 by introducing the liquid to the opening 512. The liquid sample flows through the channel 510, filling the reservoir 508 while expelling the previously contained air.
The liquid sample chemically reacts with the reagents deposited in the channel and/or reservoir 508.
[0065] The sensor strip 502 is disposed adjacent to the measurement device 502. Adjacent includes positions where the sample interface 514 is in electrical and/or optical communication with the sensor interface 508. Electrical communication includes the transfer of input and/or output signals between contacts in the sensor interface 518 and conductors in the sample interface 514.
Optical communication includes the transfer of light between an optical portal in the sample interface 514 and a detector in the sensor interface 508. Optical communication also includes the transfer of light between an optical portal in the sample interface 502 and a light source in the sensor interface 508.
[0066] While various embodiments of the invention have been described, it will be apparent to those of ordinary skill in the art that other embodiments and implementations are possible within the scope of the invention. Accordingly, the invention is not to be restricted except in light of the attached claims and their equivalents.
Claims (108)
1. A method, comprising:
applying an input signal to a sample, where the input signal has at least 3 duty cycles within 10 seconds, and where each of the at least 3 duty cycles includes an excitation pulse and a relaxation;
measuring an output signal responsive to a measurable species within 300 milliseconds of an excitation pulse of at least one duty cycle; and determining a concentration of an analyte in the sample in response to the measured output signal.
applying an input signal to a sample, where the input signal has at least 3 duty cycles within 10 seconds, and where each of the at least 3 duty cycles includes an excitation pulse and a relaxation;
measuring an output signal responsive to a measurable species within 300 milliseconds of an excitation pulse of at least one duty cycle; and determining a concentration of an analyte in the sample in response to the measured output signal.
2. The method of claim 1, further comprising measuring the output signal within 300 milliseconds from the start of the excitation pulse of the at least one duty cycle.
3. The method of claim 1, where the input signal comprises at least 4 duty cycles within 7 seconds.
4. The method of claim 1, where a pulse width of the excitation pulse is from 0.1 to 2 seconds.
5. The method of claim 1, where a pulse width of the excitation pulse is from 0.3 to 0.8 seconds.
6. The method of claim 1, where a pulse interval of at least one of the at least 3 duty cycles is less than 3 seconds.
7. The method of claim 1, where a pulse width of the excitation pulse is from 0.3 to 0.5 seconds, and where a pulse interval of at least one of the at least 3 duty cycles is from 0.7 to 2 seconds.
8. The method of claim 1, further comprising measuring the output signal within less than 175 milliseconds of the excitation pulse of the at least one duty cycle.
9. The method of claim 8, further comprising measuring the output signal within less than 175 milliseconds from the start of the excitation pulse of the at least one duty cycle.
10. The method of claim 1, further comprising measuring the output signal within 60 to 150 milliseconds from the start of the excitation pulse of the at least one duty cycle.
11. The method of claim 1, comprising:
measuring an output signal responsive to the measurable species within 300 milliseconds of the start of the excitation pulse of at least one duty cycle applied within 7 seconds of starting an initial excitation pulse.
measuring an output signal responsive to the measurable species within 300 milliseconds of the start of the excitation pulse of at least one duty cycle applied within 7 seconds of starting an initial excitation pulse.
12. The method tof claim 1, further comprising:
transferring at least one electron from the analyte in the sample to a mediator in a sensor strip; and electrochemically exciting the measurable species in response to the input signal, where the measurable species is from at least one of the analyte and the mediator.
transferring at least one electron from the analyte in the sample to a mediator in a sensor strip; and electrochemically exciting the measurable species in response to the input signal, where the measurable species is from at least one of the analyte and the mediator.
13. The method of claim 1, where the excitation pulse has a substantially constant voltage.
14. The method of claim 1, where the input signal includes square-wave excitations.
15. The method of claim 1, further comprising determining the concentration of the analyte in the sample with less bias than a concentration of the analyte determined in response to an output signal measured at more than 300 milliseconds from the start of the excitation pulse of one of the duty cycles.
16. The method of claim 15, further comprising determining the concentration of the analyte in the sample with less bias than a concentration of the analyte determined in response to an input signal having less than 3 duty cycles within 10 seconds.
17. The method of claim 1, further comprising recording at least one current as a function of time during the application of the input signal.
18. The method of claim 1, further comprising applying at least one data treatment to at least one current of the output signal.
19. The method of claim 1, further comprising:
exciting the measurable species internal to a diffusion barrier layer; and substantially excluding from excitation the measurable species external to the diffusion barrier layer.
exciting the measurable species internal to a diffusion barrier layer; and substantially excluding from excitation the measurable species external to the diffusion barrier layer.
20. The method of claim 1, where the relaxation includes a current reduction to at least one-half the current flow at an excitation maxima of the excitation pulse.
21. The method of claim 1, where the relaxation includes a current flow reduction to at least an order of magnitude less than the current flow at an excitation maxima of the excitation pulse.
22. The method of claim 1, where the relaxation includes a substantially zero current flow.
23. The method of claim 1, where the relaxation is at least 0.5 seconds.
24. The method of claim 1, further comprising determining the analyte concentration from a transient decay, where the output signal includes the transient decay.
25. The method of claim 1, where the sample is at least one of a biological fluid and a derivative of a biological fluid.
26. The method of claim 1, where the measuring is performed by a portable measurement device.
27. The method of claim 1, where the input signal comprises a terminal read pulse not followed by a relaxation.
28. A method of reducing bias in a determined concentration of an analyte in a sample, comprising:
applying an input signal to the sample, where the input signal has at least 3 duty cycles within 10 seconds, and where each of the at least 3 duty cycles comprises an excitation pulse and a relaxation;
measuring an output signal responsive to a measurable species within 300 milliseconds of an excitation pulse of at least one of the at least 3 duty cycles; and determining a concentration of the analyte in the sample in response to the measured output signal.
applying an input signal to the sample, where the input signal has at least 3 duty cycles within 10 seconds, and where each of the at least 3 duty cycles comprises an excitation pulse and a relaxation;
measuring an output signal responsive to a measurable species within 300 milliseconds of an excitation pulse of at least one of the at least 3 duty cycles; and determining a concentration of the analyte in the sample in response to the measured output signal.
29. The method of claim 28, where the input signal comprises a terminal read pulse not followed by a relaxation.
30. The method of claim 28, further comprising measuring the output signal within 300 milliseconds from the start of the excitation pulse of the at least one duty cycle.
31. The method of claim 28, where a pulse width of the excitation pulse is from 0.3 to 0.8 seconds.
32. The method of claim 28, where a pulse interval of at least one of the at least 3 duty cycles is less than 3 seconds.
33. The method of claim 28, where a pulse width of the excitation pulse is from 0.3 to 0.5 seconds, and where a pulse interval of at least one of the at least 3 duty cycles is from 0.7 to 2 seconds.
34. The method of claim 28, further comprising measuring the output signal within 60 to 150 milliseconds from the start of the excitation pulse of the at least one duty cycle.
35. The method of claim 28, further comprising measuring the output signal from the input signal within 7 seconds of an initial excitation pulse.
36. The method of claim 28, where the excitation pulse has a substantially constant voltage.
37. The method of claim 28, further comprising determining the concentration of the analyte in the sample with less bias than a concentration of the analyte determined in response to an output signal measured at more than 300 milliseconds from the start of the excitation pulse of one of the duty cycles.
38. The method of claim 37, further comprising determining the concentration of the analyte in the sample with less bias than a concentration of the analyte determined in response to an input signal having less than 3 duty cycles within 10 seconds.
39. The method of claim 28, where the relaxation includes a current flow reduction to at least one-half the current flow at an excitation maxima of the excitation pulse.
40. The method of claim 28, where the relaxation includes a current flow reduction to at least an order of magnitude less than the current flow at an excitation maxima of the excitation pulse.
41. The method of claim 28, where the relaxation includes a substantially zero current flow.
42. The method of claim 28, where the relaxation is at least 0.5 seconds and is responsive to an open circuit.
43. The method of claim 28, where at least a portion of the bias is attributable to a hematocrit effect.
44. The method of claim 28, where the sample is at least one of a biological fluid and a derivative of a biological fluid.
45. The method of claim 28, further comprising determining the analyte concentration from a transient decay, where the output signal includes the transient decay.
46. A handheld measurement device, comprising:
a sensor interface adapted to receive a sensor strip, the sensor interface including at least two contacts;
at least one display; and electronic circuitry establishing electrical communication between the at least two contacts and the display, where the electronic circuitry includes a signal generator and a processor in electrical communication, where the processor is in electrical communication with a storage medium having computer readable software code, where the processor is programmed to cause the signal generator to provide an input signal between the at least two contacts, where the input signal has at least 3 duty cycles within seconds, where each of the at least 3 duty cycles includes an excitation pulse and a relaxation, where the processor is programmed to measure at least one current value at the at least two contacts within 300 milliseconds of the signal generator applying an excitation pulse having a pulse width from 0.3 to 0.8 second of at least one duty cycle of the at least 3 duty cycles, and where the processor is programmed to determine an analyte concentration in a biological fluid or a derivative of a biological fluid in response to the at least one current value.
a sensor interface adapted to receive a sensor strip, the sensor interface including at least two contacts;
at least one display; and electronic circuitry establishing electrical communication between the at least two contacts and the display, where the electronic circuitry includes a signal generator and a processor in electrical communication, where the processor is in electrical communication with a storage medium having computer readable software code, where the processor is programmed to cause the signal generator to provide an input signal between the at least two contacts, where the input signal has at least 3 duty cycles within seconds, where each of the at least 3 duty cycles includes an excitation pulse and a relaxation, where the processor is programmed to measure at least one current value at the at least two contacts within 300 milliseconds of the signal generator applying an excitation pulse having a pulse width from 0.3 to 0.8 second of at least one duty cycle of the at least 3 duty cycles, and where the processor is programmed to determine an analyte concentration in a biological fluid or a derivative of a biological fluid in response to the at least one current value.
47. The measurement device of claim 46, where the signal generator is selected from the group consisting of an electric charger and a generator-recorder.
48. The measurement device of claim 47, where the signal generator is an electric charger.
49. The measurement device of claim 46, where the computer readable software code includes correlation equations.
50. The measurement device of claim 49, where the correlation equations are selected from the group consisting of program number tables, look-up tables, and combinations thereof.
51. The measurement device of claim 46, where the processor is programmed to measure the at least one current value during a transient portion of a current decay.
52. The measurement device of claim 51, where the processor is programmed to determine the analyte concentration in the biological fluid or the derivative of the biological fluid in response to the at least one current value measured during the transient portion of the current decay.
53. The measurement device of claim 46, where the processor is programmed to measure the at least one current value within less than 175 milliseconds from the start of the excitation pulse having the pulse width from 0.3 to 0.8 second of the at least one duty cycle.
54. The measurement device of claim 46, where the processor is programmed to apply at least one data treatment to the at least one current value.
55. The measurement device of claim 54, where the at least one data treatment determines at least one of a decay rate, a K constant, and a ratio value.
56. The measurement device of claim 48, where the processor is programmed to measure the at least one current value at the at least two contacts as a function of time while the electric charger provides the input signal between the contacts.
57. The measurement device of claim 48, where the input signal the electric charger is programmed to provide between the at least two contacts comprises at least 4 duty cycles within 7 seconds.
58. The measurement device of claim 48, where the input signal the electric charger is programmed to provide between the at least two contacts comprises square-wave excitations.
59. The measurement device of claim 48, where the electric charger is programmed to implement the excitation pulses at a substantially constant voltage.
60. The measurement device of claim 48, where the electric charger is programmed to provide a pulse width of the excitation pulse from 0.3 to 0.5 seconds.
61. The measurement device of claim 48, where the electric charger is programmed to provide a pulse width of the excitation pulse from 0.3 to 0.5 seconds, and a pulse interval of at least one of the at least 3 duty cycles from 0.7 to 2 seconds.
62. The measurement device of claim 48, where the input signal the electric charger is programmed to provide between the at least two contacts comprises a terminal read pulse not followed by a relaxation.
63. The measurement device of claim 48, where the processor is programmed to cause the electric charger to provide a pulse interval of at least one of the at least 3 duty cycles that is less than 3 seconds.
64. The measurement device of claim 48, where the processor is programmed to cause the electric charger to provide the relaxation including a current reduction to at least one-half the current flow at an excitation maxima of the excitation pulse.
65. The measurement device of claim 48, where the processor is programmed to cause the electric charger to provide the relaxation including a current reduction to at least an order of magnitude less than the current flow at an excitation maxima of the excitation pulse.
66. The measurement device of claim 48, where the processor is programmed to cause the electric charger to provide the relaxation including a substantially zero current flow.
67. The measurement device of claim 48, where the processor is programmed to measure the at least one current value from the at least one duty cycle applied by the electric charger within 7 seconds of the electric charger applying an initial excitation pulse.
68. The measurement device of claim 46, where the processor is programmed to measure the at least one current value at the at least two contacts within 60 to 150 milliseconds of the charger applying the excitation pulse having the pulse width from 0.3 to 0.8 second.
69. The measurement device of claim 48, where the processor is programmed to cause the electric charger to provide an open circuit between the at least two contacts, and where the open circuit provides the relaxation and where the relaxation is at least 0.5 seconds.
70. The measurement device of claim 46, where the input signal the signal generator is configured to provide between the at least two contacts is capable of exciting a measurable species internal to a diffusion barrier layer, and where the processor is programmed to measure the at least one current value at the at least two contacts from the measurable species internal to the diffusion barrier layer while substantially excluding from measuring the measurable species external to a diffusion barrier layer.
71. A biosensor system, comprising:
a sensor strip having a sample interface adjacent to a reservoir formed by the sensor strip; and a measurement device having a processor connected to a sensor interface, where the sensor interface has electrical communication with the sample interface, where the processor has electrical communication with a storage medium, where the processor is programmed to determine an output signal value responsive to the concentration of an analyte in a sample from the sensor interface within 300 milliseconds of applying an excitation pulse having a pulse width from 0.3 to 0.8 second to the sample interface, and where the excitation pulse is part of an input signal having at least 3 duty cycles within 10 seconds, where each duty cycle includes an excitation pulse and a relaxation.
a sensor strip having a sample interface adjacent to a reservoir formed by the sensor strip; and a measurement device having a processor connected to a sensor interface, where the sensor interface has electrical communication with the sample interface, where the processor has electrical communication with a storage medium, where the processor is programmed to determine an output signal value responsive to the concentration of an analyte in a sample from the sensor interface within 300 milliseconds of applying an excitation pulse having a pulse width from 0.3 to 0.8 second to the sample interface, and where the excitation pulse is part of an input signal having at least 3 duty cycles within 10 seconds, where each duty cycle includes an excitation pulse and a relaxation.
72. The system of claim 71, where the measurement device is portable.
73. The system of claim 71, where the excitation pulse has a substantially constant voltage.
74. The system of claim 71, where the processor is programmed to determine the output signal value responsive to the concentration of the analyte in the sample during a transient portion of a current decay.
75. The system of claim 71, where a pulse interval of at least one of the at least 3 duty cycles is less than 3 seconds.
76. The system of claim 71, where a pulse width of the excitation pulse is from 0.3 to 0.5 seconds, and where a pulse interval of at least one of the at least 3 duty cycles is from 0.7 to 2 seconds.
77. The system of claim 71, where the relaxation includes a current reduction to at least one-half the current flow at an excitation maxima of the excitation pulse.
78. The system of claim 71, where the relaxation includes a current flow reduction to at least an order of magnitude less than the current flow at an excitation maxima of the excitation pulse.
79. The system of claim 71, where the relaxation includes a substantially zero current flow.
80. The system of claim 71, where the processor is programmed to determine the output signal value responsive to the concentration of the analyte in the sample within 60 to 150 milliseconds of applying the excitation pulse to the sample interface.
81. The system of claim 71, where the relaxation is at least 0.5 seconds and is responsive to an open circuit.
82. The system of claim 71, where the sample is at least one of a biological fluid and a derivative of a biological fluid.
83. A method, comprising:
applying an input signal to a sample, wherein the input signal has at least 3 duty cycles within 30 seconds, and wherein each of the at least 3 duty cycles includes an excitation pulse and a relaxation;
measuring an output signal responsive to a measurable species within 300 milliseconds from the start of an excitation pulse of at least one of the at least 3 duty cycles, wherein a pulse width of the excitation pulse is from 0.1 to 2 seconds; and determining a concentration of an analyte in the sample in response to the measured output signal.
applying an input signal to a sample, wherein the input signal has at least 3 duty cycles within 30 seconds, and wherein each of the at least 3 duty cycles includes an excitation pulse and a relaxation;
measuring an output signal responsive to a measurable species within 300 milliseconds from the start of an excitation pulse of at least one of the at least 3 duty cycles, wherein a pulse width of the excitation pulse is from 0.1 to 2 seconds; and determining a concentration of an analyte in the sample in response to the measured output signal.
84. The method of claim 83, wherein the input signal comprises at least 4 duty cycles within 7 seconds.
85. The method of claim 83, wherein the input signal comprises at least 3 duty cycles within 10 seconds.
86. The method of claim 83, wherein a pulse width of the excitation pulse is from 0.3 to 0.8 seconds.
87. The method of claim 83, wherein a pulse interval of at least one of the at least 3 duty cycles is less than 3 seconds.
88. The method of claim 83, wherein a pulse width of the excitation pulse is from 0.3 to 0.5 seconds, and wherein a pulse interval of at least one of the at least 3 duty cycles is from 0.7 to 2 seconds.
89. The method of claim 83, wherein the measuring the output signal occurs within less than 175 milliseconds of the excitation pulse.
90. The method of claim 83, wherein the measuring the output signal occurs within 60 to 150 milliseconds from the start of the excitation pulse.
91. The method of claim 83, further comprising:
transferring at least one electron from the analyte in the sample to a mediator in a sensor strip; and electrochemically exciting the measurable species in response to the input signal, wherein the measurable species is from at least one of the analyte and the mediator.
transferring at least one electron from the analyte in the sample to a mediator in a sensor strip; and electrochemically exciting the measurable species in response to the input signal, wherein the measurable species is from at least one of the analyte and the mediator.
92. The method of claim 83, wherein the excitation pulse has a substantially constant voltage.
93. The method of claim 83, wherein the input signal includes square-wave excitations.
94. The method of claim 83, wherein the determining the concentration of the analyte in the sample is carried out with less bias than a concentration of the analyte determined in response to an output signal measured at more than 300 milliseconds from the start of the excitation pulse of one of the duty cycles.
95. The method of claim 94, wherein the determining the concentration of the analyte in the sample is carried out with less bias than a concentration of the analyte determined in response to an input signal having less than 3 duty cycles within 10 seconds.
96. The method of claim 83, further comprising recording at least one current as a function of time during the application of the input signal.
97. The method of claim 83, further comprising applying at least one data treatment to at least one current of the output signal, wherein the at least one data treatment determines at least one of a decay rate, a K constant, and a ratio value.
98. The method of claim 83, further comprising:
exciting the measurable species internal to a diffusion barrier layer; and substantially excluding from excitation the measurable species external to the diffusion barrier layer.
exciting the measurable species internal to a diffusion barrier layer; and substantially excluding from excitation the measurable species external to the diffusion barrier layer.
99. The method of claim 83, wherein the relaxation includes a current reduction to at least one-half the current flow at an excitation maxima of the excitation pulse.
100. The method of claim 83, wherein the relaxation includes a current flow reduction to at least an order of magnitude less than the current flow at an excitation maxima of the excitation pulse.
101. The method of claim 83, wherein the relaxation includes a substantially zero current flow or an open circuit.
102. The method of claim 101, wherein the relaxation is at least 0.5 seconds.
103. The method of claim 83, wherein the determining the analyte concentration includes determining the analyte concentration from a transient decay, wherein the output signal includes the transient decay.
104. The method of claim 83, wherein the sample is at least one of a biological fluid and a derivative of a biological fluid.
105. The method of claim 83, wherein the measuring is performed by a portable measurement device.
106. The method of claim 83, wherein the input signal comprises a terminal read pulse not followed by a relaxation.
107. The method of claim 83, wherein the measuring the output signal occurs within less than 175 milliseconds from the start of the excitation pulse, wherein the excitation pulse has the pulse width from 0.3 to 0.8 second.
108. The method of claim 83, wherein the measuring the output signal occurs within 60 to 150 milliseconds from the start of the excitation pulse, wherein the excitation pulse has the pulse width from 0.3 to 0.8 second.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1272907P | 2007-12-10 | 2007-12-10 | |
| US61/012,729 | 2007-12-10 | ||
| PCT/US2008/080865 WO2009075951A1 (en) | 2007-12-10 | 2008-10-23 | Rapid-read gated amperometry |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2707300A1 CA2707300A1 (en) | 2009-06-18 |
| CA2707300C true CA2707300C (en) | 2017-09-26 |
Family
ID=40120419
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2707300A Expired - Fee Related CA2707300C (en) | 2007-12-10 | 2008-10-23 | Rapid-read gated amperometry |
Country Status (10)
| Country | Link |
|---|---|
| US (5) | US8147674B2 (en) |
| EP (3) | EP3395954B1 (en) |
| JP (1) | JP5455924B2 (en) |
| CN (2) | CN101896619B (en) |
| BR (1) | BRPI0820718A2 (en) |
| CA (1) | CA2707300C (en) |
| MX (1) | MX2010006393A (en) |
| RU (1) | RU2491549C2 (en) |
| TW (1) | TWI468679B (en) |
| WO (1) | WO2009075951A1 (en) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005078118A1 (en) | 2004-02-06 | 2005-08-25 | Bayer Healthcare Llc | Oxidizable species as an internal reference for biosensors and method of use |
| AU2006272909B2 (en) * | 2005-07-20 | 2013-02-07 | Bayer Healthcare Llc | Gated amperometry |
| WO2008036516A1 (en) | 2006-09-22 | 2008-03-27 | Bayer Healthcare Llc | Biosensor system having enhanced stability and hematocrit performance |
| CN101896619B (en) * | 2007-12-10 | 2017-04-05 | 安晟信医疗科技控股公司 | Rapid-read gated amperometry |
| WO2009076302A1 (en) | 2007-12-10 | 2009-06-18 | Bayer Healthcare Llc | Control markers for auto-detection of control solution and methods of use |
| JP5773883B2 (en) | 2008-12-08 | 2015-09-02 | バイエル・ヘルスケア・エルエルシーＢａｙｅｒ ＨｅａｌｔｈＣａｒｅＬＬＣ | Low total salt reagent compositions and systems for biosensors |
| US9233788B2 (en) | 2010-01-22 | 2016-01-12 | Bayer Healthcare Llc | Biosensor desiccant system having enhanced measurement performance |
| TWI565943B (en) | 2011-07-22 | 2017-01-11 | 拜耳保健公司 | Biosensor desiccant system having enhanced measurement performance |
| EP2919000B1 (en) | 2012-12-12 | 2019-05-08 | PHC Holdings Corporation | Blood component measuring device and method for measuring blood component |
| WO2014140173A1 (en) | 2013-03-15 | 2014-09-18 | Roche Diagnostics Gmbh | Descriptor-based methods of electrochemically measuring an analyte as well as devices, apparatuses and systems incoporating the same |
| EP3388823A1 (en) | 2013-03-15 | 2018-10-17 | Roche Diabetes Care GmbH | Methods of scaling data used to construct biosensor algorithms as well as devices, apparatuses and systems incorporating the same |
| WO2014140178A1 (en) * | 2013-03-15 | 2014-09-18 | Roche Diagnostics Gmbh | Methods of electrochemically measuring an analyte with a test sequence having a pulsed dc block as well as devices, apparatuses and systems incorporating the same |
| WO2014140172A1 (en) | 2013-03-15 | 2014-09-18 | Roche Diagnostics Gmbh | Methods of failsafing electrochemical measurements of an analyte as well as devices, apparatuses and systems incorporating the same |
| JP6356707B2 (en) | 2013-03-15 | 2018-07-11 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | Method for detecting high antioxidant levels during electrochemical measurements and then fail-safe analyte concentration and devices, apparatus and systems incorporating the same |
| JP6352954B2 (en) | 2013-03-15 | 2018-07-04 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | Method and device for using information from recovery pulses in electrochemical analyte measurement, apparatus and system incorporating them |
| US9738916B2 (en) | 2013-07-08 | 2017-08-22 | Panasonic Healthcare Holdings Co., Ltd. | Blood component measurement device and blood component measurement method |
| KR101666978B1 (en) | 2014-09-17 | 2016-10-24 | 주식회사 아이센스 | Apparatus and Method for measuring concentration of Whole Blood Samples Using the same |
| CA3028348A1 (en) | 2016-07-12 | 2018-01-18 | Ascensia Diabetes Care Holdings Ag | Method for electrochemical analysis by use of alternating output signals from two electrodes |
| CA3045090A1 (en) * | 2016-12-05 | 2018-06-14 | Ascensia Diabetes Care Holdings Ag | Risk factor monitoring |
| CN110954687B (en) * | 2019-11-18 | 2022-06-07 | 深圳微点生物技术股份有限公司 | Method and device for detecting blood coagulation |
| WO2022130229A1 (en) * | 2020-12-17 | 2022-06-23 | S2G Technologies S.R.L. Startup Costituita Ai Sensi Dell'art. 4, Comma10-Bis D.L. 3/2015 Convertito Con Legge 33/2015 | Device for analysing a biological fluid |
| US20220245408A1 (en) * | 2021-01-20 | 2022-08-04 | Rutgers, The State University Of New Jersey | Method of Calibration Using Master Calibration Function |
Family Cites Families (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4994167A (en) | 1986-04-15 | 1991-02-19 | Markwell Medical Institute, Inc. | Biological fluid measuring device |
| US4897162A (en) | 1986-11-14 | 1990-01-30 | The Cleveland Clinic Foundation | Pulse voltammetry |
| DE68924026T3 (en) | 1988-03-31 | 2008-01-10 | Matsushita Electric Industrial Co., Ltd., Kadoma | BIOSENSOR AND ITS MANUFACTURE. |
| US5131999A (en) | 1990-01-16 | 1992-07-21 | The National University Of Singapore | Voltammetric detector for flow analysis |
| DE69229994T2 (en) | 1991-03-07 | 2000-04-27 | Masimo Corp | DEVICE AND METHOD FOR SIGNAL PROCESSING |
| US5756362A (en) | 1993-10-12 | 1998-05-26 | Cornell Research Foundation, Inc. | Liposome-enhanced immunoaggregation assay and test device |
| IE72524B1 (en) | 1994-11-04 | 1997-04-23 | Elan Med Tech | Analyte-controlled liquid delivery device and analyte monitor |
| US6153069A (en) | 1995-02-09 | 2000-11-28 | Tall Oak Ventures | Apparatus for amperometric Diagnostic analysis |
| US5620579A (en) | 1995-05-05 | 1997-04-15 | Bayer Corporation | Apparatus for reduction of bias in amperometric sensors |
| AUPN661995A0 (en) | 1995-11-16 | 1995-12-07 | Memtec America Corporation | Electrochemical cell 2 |
| US5708247A (en) | 1996-02-14 | 1998-01-13 | Selfcare, Inc. | Disposable glucose test strips, and methods and compositions for making same |
| CA2225334A1 (en) | 1996-04-22 | 1997-10-30 | Imra Japan Kabushikikaisha | Co gas sensor and method of measuring the concentration of co gas |
| US6391558B1 (en) * | 1997-03-18 | 2002-05-21 | Andcare, Inc. | Electrochemical detection of nucleic acid sequences |
| JP2002505008A (en) * | 1997-06-16 | 2002-02-12 | エラン コーポレーション ピーエルシー | Methods for calibrating and testing sensors for in vivo measurement of analytes and devices for use in such methods |
| AU3849799A (en) * | 1998-05-20 | 1999-12-06 | Arkray, Inc. | Method and apparatus for electrochemical measurement using statistical technique |
| JP4352108B2 (en) * | 1998-12-15 | 2009-10-28 | アークレイ株式会社 | Substrate quantification method |
| US6475372B1 (en) | 2000-02-02 | 2002-11-05 | Lifescan, Inc. | Electrochemical methods and devices for use in the determination of hematocrit corrected analyte concentrations |
| JP2001021525A (en) * | 1999-07-02 | 2001-01-26 | Akebono Brake Res & Dev Center Ltd | Measuring method using biosensor |
| JP4288775B2 (en) | 1999-07-29 | 2009-07-01 | 株式会社エクォス・リサーチ | CO gas sensor |
| ES2298155T3 (en) * | 1999-09-20 | 2008-05-16 | Roche Diagnostics Operations, Inc. | METHOD FOR MONITORING AN ANALYTE USING AN ELECTROCHEMICAL BIOSENSOR THAT CAN BE DISCONNECTED BY APPLYING AN ELECTRICAL POTENTIAL. |
| JP4050434B2 (en) * | 1999-11-29 | 2008-02-20 | 松下電器産業株式会社 | Sample discrimination method |
| EP2202511A3 (en) * | 2001-01-17 | 2010-09-29 | ARKRAY, Inc. | Quantitative analyzing method and quantitative analyzer using sensor |
| WO2002077633A1 (en) | 2001-03-23 | 2002-10-03 | The Regents Of The University Of California | Open circuit potential amperometry and voltammetry |
| DE10119527A1 (en) * | 2001-04-12 | 2002-11-07 | Sitec Sensortechnik Gmbh | Method for the mobile or stationary acquisition of body function and metabolic data of a living body and device for carrying out the method |
| US6721586B2 (en) | 2001-06-12 | 2004-04-13 | Lifescan, Inc. | Percutaneous biological fluid sampling and analyte measurement devices and methods |
| US20030113933A1 (en) | 2001-12-18 | 2003-06-19 | Rasmus Jansson | Analysis of components in liquids |
| AU2003203004B2 (en) | 2002-01-15 | 2008-05-01 | Agamatrix, Inc. | Method and apparatus for processing electrochemical signals |
| CN100504371C (en) | 2002-07-25 | 2009-06-24 | 爱科来株式会社 | Sample analyzing method and sample analyzing device |
| WO2004053476A1 (en) | 2002-12-09 | 2004-06-24 | Otre Ab | Simplified signal processing method for voltammetry |
| JP4449431B2 (en) | 2003-11-19 | 2010-04-14 | パナソニック株式会社 | Substrate concentration measurement method |
| WO2005073708A2 (en) | 2004-01-29 | 2005-08-11 | Siemens Aktiengesellschaft | Method for measuring the concentration or change in concentration of a redox-active substance and corresponding device |
| RU2386960C2 (en) * | 2004-05-14 | 2010-04-20 | БАЙЕР ХЕЛТКЭР ЭлЭлСи | Voltammetric system for analysing biological substances |
| CA2887517C (en) | 2004-10-12 | 2017-09-12 | Bayer Healthcare Llc | Concentration determination in a diffusion barrier layer |
| JP2008517658A (en) * | 2004-10-21 | 2008-05-29 | バイエル・ヘルスケア・エルエルシー | Method and apparatus for measuring analyte concentration in body fluid |
| US8452365B2 (en) * | 2005-05-25 | 2013-05-28 | Bayer Healthcare Llc | Methods of using Raman spectral information in determining analyte concentrations |
| AU2006272909B2 (en) * | 2005-07-20 | 2013-02-07 | Bayer Healthcare Llc | Gated amperometry |
| AU2006297572B2 (en) * | 2005-09-30 | 2012-11-15 | Ascensia Diabetes Care Holdings Ag | Gated Voltammetry |
| US7468125B2 (en) | 2005-10-17 | 2008-12-23 | Lifescan, Inc. | System and method of processing a current sample for calculating a glucose concentration |
| EP2020909A2 (en) * | 2006-05-08 | 2009-02-11 | Bayer HealthCare LLC | Abnormal output detection system for a biosensor |
| WO2008036516A1 (en) * | 2006-09-22 | 2008-03-27 | Bayer Healthcare Llc | Biosensor system having enhanced stability and hematocrit performance |
| EP2679150B1 (en) * | 2006-10-24 | 2020-07-22 | Ascensia Diabetes Care Holdings AG | Transient decay amperometry |
| BRPI0814202B1 (en) | 2007-07-26 | 2019-10-29 | Home Diagnostics Inc | methods and systems for determining the concentration of analytical fluid sample |
| US8101062B2 (en) | 2007-07-26 | 2012-01-24 | Nipro Diagnostics, Inc. | System and methods for determination of analyte concentration using time resolved amperometry |
| CN101896619B (en) * | 2007-12-10 | 2017-04-05 | 安晟信医疗科技控股公司 | Rapid-read gated amperometry |
-
2008
- 2008-10-23 CN CN200880120045.5A patent/CN101896619B/en active Active
- 2008-10-23 CN CN201710080974.9A patent/CN107091870B/en active Active
- 2008-10-23 EP EP18176551.2A patent/EP3395954B1/en active Active
- 2008-10-23 BR BRPI0820718-6A patent/BRPI0820718A2/en not_active Application Discontinuation
- 2008-10-23 RU RU2010128649/15A patent/RU2491549C2/en active
- 2008-10-23 WO PCT/US2008/080865 patent/WO2009075951A1/en active Application Filing
- 2008-10-23 EP EP08860137.2A patent/EP2222867B1/en active Active
- 2008-10-23 JP JP2010538008A patent/JP5455924B2/en active Active
- 2008-10-23 EP EP20165626.1A patent/EP3690058B1/en active Active
- 2008-10-23 CA CA2707300A patent/CA2707300C/en not_active Expired - Fee Related
- 2008-10-23 MX MX2010006393A patent/MX2010006393A/en active IP Right Grant
- 2008-11-10 TW TW97143312A patent/TWI468679B/en not_active IP Right Cessation
- 2008-11-14 US US12/271,032 patent/US8147674B2/en active Active
-
2012
- 2012-02-21 US US13/401,222 patent/US9034160B2/en active Active
-
2015
- 2015-04-16 US US14/688,055 patent/US10345255B2/en active Active
-
2019
- 2019-05-22 US US16/419,957 patent/US10908112B2/en active Active
-
2021
- 2021-01-13 US US17/148,293 patent/US20210148851A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN107091870B (en) | 2019-10-08 |
| MX2010006393A (en) | 2010-06-25 |
| US10908112B2 (en) | 2021-02-02 |
| JP5455924B2 (en) | 2014-03-26 |
| US20090145779A1 (en) | 2009-06-11 |
| EP3690058B1 (en) | 2021-12-29 |
| US20210148851A1 (en) | 2021-05-20 |
| US8147674B2 (en) | 2012-04-03 |
| US20120211361A1 (en) | 2012-08-23 |
| CA2707300A1 (en) | 2009-06-18 |
| EP3690058A1 (en) | 2020-08-05 |
| US9034160B2 (en) | 2015-05-19 |
| EP3395954A1 (en) | 2018-10-31 |
| EP3395954B1 (en) | 2020-07-01 |
| US20150219586A1 (en) | 2015-08-06 |
| EP2222867B1 (en) | 2018-07-11 |
| WO2009075951A1 (en) | 2009-06-18 |
| RU2491549C2 (en) | 2013-08-27 |
| TW200925592A (en) | 2009-06-16 |
| US20190331630A1 (en) | 2019-10-31 |
| US10345255B2 (en) | 2019-07-09 |
| JP2011506964A (en) | 2011-03-03 |
| BRPI0820718A2 (en) | 2015-06-16 |
| CN101896619A (en) | 2010-11-24 |
| RU2010128649A (en) | 2012-01-20 |
| TWI468679B (en) | 2015-01-11 |
| EP2222867A1 (en) | 2010-09-01 |
| CN101896619B (en) | 2017-04-05 |
| CN107091870A (en) | 2017-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10908112B2 (en) | Rapid-read gated amperometry devices | |
| US10989683B2 (en) | Identifying ionizable species with voltammetric duty cycles | |
| US8877035B2 (en) | Gated amperometry methods | |
| EP2223104B1 (en) | Slope-based compensation | |
| ES2690649T3 (en) | Rapidly read pulse controlled amperometry |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20141022 |
|
| MKLA | Lapsed |
Effective date: 20211025 |